Add to MyYahoo RSS

Amylin Pharmaceuticals News

News on Amylin Pharmaceuticals (Ticker: AMLN) continually updated from thousands of sources around the net.

May 13, 2014 | Sys-Con Media

Liquid Grids Announces Series A Funding and Appoints New Chairman

Liquid GridsA , a Precision Marketing Platform marketing for the Healthcare Industry, has recently completed a Series A investment round led by Miramar Digital Ventures .


Related Topix: Marketing, Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry, Frank Sinatra, Jazz, Scientific Instruments, Illumina, Keck Graduate Institute

Texas Tech Football #ALSIceBucketChallenge

This Woman Looks Like She's Wearing Makeup. She's Not.

Critics Slam 'Ice Bucket Challenge' as 'Slacktivism' and 'Stunt Philanthropy'

Police Fatally Shoot Another Black Male Near Ferguson

Sun Apr 13, 2014

The San Diego Union-Tribune

Partner at Domain seeks out innovators

Kim Kamdar of Domain Associates says the company is excited about biotech and medical device companies in the effort to tailor medicine to specific patients.


Related Topix: Amgen, Biotech, Medicine, Healthcare Industry

Thu Mar 27, 2014

Seeking Alpha

AstraZeneca's New Diabetes Drug May Also Combat Alzheimer's Disease

A relatively new diabetes drug, Symlin , developed by AstraZeneca's Amylin Pharmaceuticals has been found to combat a major component of Alzheimer's disease and may offer a new treatment option for the millions of Americans with the memory-robbing condition.


Related Topix: Biotech, AstraZeneca Group, Medicine, Diabetes, Health, Alzheimer's, Healthcare Industry, Insulin (generic), Humulin, Novolin, Pharmacology

Mon Mar 24, 2014

Fox News

Novo Nordisk Upgraded to 'Buy'

Novo Nordisk was handed an upgrade to "buy" from "hold" on Tuesday from Austria's Erste Group, helping to boost its shares 1%.


Related Topix: Biotech, Novo Nordisk AS, Bristol Myers Squibb, Medicine, Healthcare Industry, Business News

Wed Feb 26, 2014

Pharmaceutical Technology

FDA Approves Orphan Drug Myalept

AstraZeneca announced FDA approved orphan drug Myalept , which is indicated as an adjunct to diet as replacement therapy for the treatment of complications of leptin deficiency in patientswith congenital or acquired generalized lipodystrophy.


Related Topix: Biotech, Medicine, Healthcare Industry, Marketing


Ashburn Jobs